Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

Completed · Phase 3 · Has a placebo group

Conditions studied: PONV

In brief

A comparison of the efficacy of APD421 and placebo when combined with a standard anti-emetic in the prevention of PONV in patients at high risk of Post-operative Nausea and Vomiting (PONV).

Key facts

Study ID
NCT02337062
Run by
Acacia Pharma Ltd
People needed
1147
Starts
2015-02-01
Expected to finish
2015-09-01
Last updated by the study team
2019-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.